Literature DB >> 23370424

Detection of minor clones with internal tandem duplication mutations of FLT3 gene in acute myeloid leukemia using delta-PCR.

Katie Beierl1, Li-Hui Tseng, Russell Beierl, Lisa Haley, Christopher D Gocke, James R Eshleman, Ming-Tseh Lin.   

Abstract

Internal tandem duplication (ITD) mutations of the FLT3 gene have been associated with inferior prognosis of acute myeloid leukemia. Detection of minor clones or minimal residual clones with ITD mutations is desirable, but is challenging when the mutant signal determined by polymerase chain reaction (PCR) and capillary electrophoresis is weak. In this study, we applied delta-PCR, which is a triple-primer strategy, to ensure PCR specificity and improve the sensitivity to 0.1% leukemic cells with ITD mutation. We also applied a reference peak to calculate ITD allelic burdens of <2% threshold of technical limitation for evaluating the relative ratio of 2 signals by capillary electrophoresis. Delta-PCR was able to detect single or multiple ITD mutations with an allelic burden (peak height ratio of mutant allele and wild-type allele) ranging from 0.4% to >100% among all 31 cases with previous documented ITD mutations. In one of the 3 cases with previously reported negative ITD mutation in the initial diagnostic specimen and ITD-positive results in the follow-up specimens, an ITD of 0.04% allele burden was retrospectively detected in the initial diagnosis specimen using delta-PCR. We also demonstrated that minor ITD mutant clones with an allelic burden of <1% present at diagnosis may become a dominant clone at the later refractory status, suggesting that detection of leukemic clones with allelic burdens of <1% may be clinically significant. Delta-PCR can detect ITD mutations with improved sensitivity and specificity and may be useful for the detection of minimal residual leukemia.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23370424     DOI: 10.1097/PDM.0b013e31825d81f4

Source DB:  PubMed          Journal:  Diagn Mol Pathol        ISSN: 1052-9551


  6 in total

Review 1.  FLT3-ITD and its current role in acute myeloid leukaemia.

Authors:  Francisco Alejandro Lagunas-Rangel; Venice Chávez-Valencia
Journal:  Med Oncol       Date:  2017-05-03       Impact factor: 3.064

Review 2.  Minimal residual disease in acute myeloid leukaemia.

Authors:  Christopher S Hourigan; Judith E Karp
Journal:  Nat Rev Clin Oncol       Date:  2013-06-25       Impact factor: 66.675

3.  Tandem duplication PCR: an ultrasensitive assay for the detection of internal tandem duplications of the FLT3 gene.

Authors:  Ming-Tseh Lin; Li-Hui Tseng; Katie Beierl; Antony Hsieh; Michele Thiess; Nadine Chase; Amanda Stafford; Mark J Levis; James R Eshleman; Christopher D Gocke
Journal:  Diagn Mol Pathol       Date:  2013-09

4.  Clinical validation of KRAS, BRAF, and EGFR mutation detection using next-generation sequencing.

Authors:  Ming-Tseh Lin; Stacy L Mosier; Michele Thiess; Katie F Beierl; Marija Debeljak; Li-Hui Tseng; Guoli Chen; Srinivasan Yegnasubramanian; Hao Ho; Leslie Cope; Sarah J Wheelan; Christopher D Gocke; James R Eshleman
Journal:  Am J Clin Pathol       Date:  2014-06       Impact factor: 2.493

5.  Quantitative fragment analysis of FLT3-ITD efficiently identifying poor prognostic group with high mutant allele burden or long ITD length.

Authors:  Y Kim; G D Lee; J Park; J-H Yoon; H-J Kim; W-S Min; M Kim
Journal:  Blood Cancer J       Date:  2015-08-14       Impact factor: 11.037

Review 6.  Molecular testing for acute myeloid leukemia.

Authors:  Dahui Qin
Journal:  Cancer Biol Med       Date:  2021-08-04       Impact factor: 4.248

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.